My research interests are in the mechanism of human inflammatory diseases, especially autoimmune and neuroinflammatory disorders. I work within both academia settings (London, Oxford, Boston, Exeter Universities) and the Pharma industry (UCB & Revolo Biotherapeutics) in many cross-disciplinary biomedical areas: autoimmunity (RA, SLE and MS), neurology (PD, ALS, AZ), innate and adaptive immunity, cancer, inflammation, medical microbiology, and hyperbaric medicine. I am currently Hon Prof of Immunology (Exeter Medical School) and Vice President of Immunology (Revolo Biotherapeutics). My current work focusses on developing chaperone peptide/protein biologics to sustain long term tolerogenic immunity in inflammatory disorders in allergy and autoimmunity. This involves working with CRO's and academic groups worldwide to direct our pre-clinical and clinical trial work towards developing therapeutics that can restore dysfunctional patient immunity back to a balanced immune homeostasis.